Study hints antibody drug produced by ‘Eli Lilly’ may cut COVID-19 hospitalisations
Washington: Drug company ‘Eli Lilly’ has said that partial results from a study testing an antibody drug give hints that it may help mild to moderately ill COVID-19 patients from needing to be hospitalized. It is something that no current coronavirus medicine has been able...











































